NPJ Precision Oncology · Jul 23, 2026

Non-invasive esophageal cancer screening in high-risk populations: a multi-omics integration model

By Li W, Cui Y, Wu J et al.

Esophageal cancer (ESCA) is a leading cause of cancer-related mortality in China, with over 95% of patients diagnosed at advanced stages, resulting in low survival rates. Early detection is critical for improving outcomes, yet current screening methods are invasive or lack sensitivity. We developed a non-invasive early-detection model by integrating circulating cell-free DNA (cfDNA) methylation and fragmentomics features. Using a three-layer stacked ensemble machine learning framework, we analyzed multicenter blood samples from 309 participants, including ESCA patients and high-risk individuals. The integrated model called ESim-seq (Esophageal Cancer Screening with Integrated Model) achieved an AUC of 0.994 (95% CI: 0.979-1.000) in validation. At 99% specificity, sensitivity reached 87.3%, with simulated screening showing a 24.8% increase in stage I detection. Stratified analyses confirmed robustness across demographics, risk factors, and tumor stages. Clinical benefit modeling projected a 56.3% stage I detection rate under ideal conditions, significantly improving survival outcomes compared to standard care. This study developed a cfDNA-based analytical framework and demonstrated the advantage of multi-feature integration for early detection of ESCA.

doi.org/10.1038/s41698-026-01620-wOpen accessPubMed 43020857Biomarkers

AgingResearch.News